IMMUNE EFFECTOR CELL-ASSOCIATED HAEMATOTOXICITY

This adverse event was reported 174 times

IMMUNE EFFECTOR CELL-ASSOCIATED HAEMATOTOXICITY is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 SILTUXIMAB 19 0.0293
1 OBECABTAGENE AUTOLEUCEL 1 0.0141
2 CILTACABTAGENE AUTOLEUCEL 57 0.0087
3 BREXUCABTAGENE AUTOLEUCEL 18 0.0083
4 IDECABTAGENE VICLEUCEL 8 0.0064
5 AXICABTAGENE CILOLEUCEL 58 0.0057
6 IMMUNE GLOBULIN INTRAVENOUS, HUMAN - DIRA 1 0.0040
7 LISOCABTAGENE MARALEUCEL 2 0.0023
8 DALBAVANCIN HYDROCHLORIDE 1 0.0021
9 TOCILIZUMAB-AAZG 1 0.0016
See all drugs enriched for association with IMMUNE EFFECTOR CELL-ASSOCIATED HAEMATOTOXICITY